Antibiotics are the answer.
Except when they’re not.
Introducing the BacterioScan 216Dx System
Now you can have fast and accurate urinary tract infection results to inform effective treatment decisions.
The only FDA 510(k)-cleared test for UTI detection directly from urine.
Slow UTI test results compromise high standards of care and force unnecessary antibiotic prescriptions.
60% to 90% of UTI tests report negative.
Slow UTI tests can result in patient frustration and unnecessary prescriptions, which may increase the risk of side effects and drug interactions.
Overprescription of antibiotics can potentially lead to the development of
antibiotic resistance, downstream complications, and added expense.
60% to 90% of UTI tests report negative.
Slow UTI tests can result in patient frustration and unnecessary prescriptions, which may increase the risk of side effects and drug interactions.
Overprescription of antibiotics can potentially lead to the development of
antibiotic resistance, downstream complications, and added expense.
THE BACTERIOSCAN 216DX SYSTEM GETS RESULTS IN:
3 HOURS
Using light scattering technology the BacterioScan 216Dx System can measure urine and broth turbidity in just 3 hours.
THE BACTERIOSCAN 216DX SYSTEM GETS RESULTS IN:
3 HOURS
Using light scattering technology the BacterioScan 216Dx System can measure urine and broth turbidity in just 3 hours.
THE FUTURE OF EARLY DETECTION TECHNOLOGY
With the BacterioScan 216Dx’s 3 hour turnaround time, results are available 1-2 days faster than current methods, for quicker detection of infection and better patient care
3 Hours to Improved Patient Care
- 3 hour test results with > 97.7% sensitivity for fast, accurate reporting
- Change or stop unneeded antibiotic prescriptions
- Quicker detection of infection expedites ID and AST processes
3 Hours to Improved Antibiotic Stewardship
- Opportunity to reduce broad spectrum antibiotic consumption
- Targeted antibiotic therapy to treat specific bacterial infection
- Improve infection control practices for earlier patient discharge
3 Hours to Improved Lab and Hospital Economics
- 3 hour turn-around-time enables labs to report results earlier
- Eliminate the need to culture negative urine specimens
- Reduce the time and effort dedicated to plating urines by 50%
BACTERIOSCAN 216DX
CLINICAL PERFORMANCE
BacterioScan’s 216Dx laser microbial growth monitor has been extensively studied in clinical microbiology laboratories worldwide
When evaluating specimens with uropathogens present at 50,000 CFU/mL or greater, the 216Dx delivers:
Sensitivity
NEGATIVE PREDICTIVE VALUE
When evaluating specimens with uropathogens present at 50,000 CFU/mL or greater, the 216Dx delivers:
Sensitivity
NEGATIVE PREDICTIVE VALUE
Results from 3,000 sample clinical study across three US hospital laboratories.
The science behind our platform makes answers before antibiotics possible.
Expedited diagnostics such as BacterioScan’s could transform the fight against antibiotic resistant bacteria and change the way we use antibiotics.
Our proprietary and patented laser microbial growth technology platform is built on the fast detection and antibiotic susceptibility testing that enables early detection of infectious pathogens. We produce reliable, precision instrumentation that quickly detects and measures microorganism growth in liquid specimens, and determines if it is resistant to a range of antibiotics and provides clinicians with patient-specific guidance on the fastest and most cost-effective antibiotic treatment.
HEADQUARTERS
2210 Welsch Industrial Court,
St. Louis, MO 63146, USA
PHONE
844-222-7226